Key Highlights
- DOCS shares traded up 7.49% to $33.81, versus a prior close of $31.45.
- UpToDate's 13,000 clinical topics will be accessible inside Doximity Ask in the coming weeks.
- Doximity's network includes more than 85% of U.S. physicians.
- Its Clinical AI Suite is deployed across more than 165 health systems.
- The 52-week high is $71.37, far above the current price.
UpToDate Partnership Adds Expert-Written Content to Doximity Ask
Doximity (NYSE:DOCS) shares traded up 7.49% to $33.81 after the company and Wolters Kluwer Health announced that UpToDate's evidence-based clinical content will be accessible within Doximity Ask. In the coming weeks, clinicians at health systems using both products will see answers based on UpToDate's 13,000 topics and best practice guides alongside the Ask answer.
Doximity said the pairing lets physicians get a second opinion without leaving their workflow. UpToDate draws on about 7,600 expert clinicians, editors and peer reviewers who regularly review its content.
Platform Reaches More Than 85% of U.S. Physicians
Founded in 2010 and based in San Francisco, Doximity operates a digital platform for U.S. medical professionals with messaging, telehealth, scheduling and AI workflow tools such as Ask and Scribe. Most of its revenue comes from subscription marketing and hiring solutions sold to pharmaceutical manufacturers and health systems.
Its Clinical AI Suite, including Ask, is deployed across more than 165 health systems, including 10 of the nation's top 20 hospitals. A program of more than 12,000 cited physician experts evaluates and helps improve Ask outputs.
A Stock Still Far Below Its High Despite a Cautious Analyst Backdrop
Doximity has a market capitalization of about $6.03 billion, a trailing price-to-earnings ratio of 39.76 and earnings per share of $1.53. The 52-week range runs from $17.15 to $71.37.
Bank of America raised its price target to $23 from $20 while maintaining an Underperform rating, and analyst consensus is Hold. A securities class action over alleged newsfeed overstatement, with a November 16 lead plaintiff deadline, remains an overhang.
November 5 Fiscal Second-Quarter Results Are the Next Catalyst
Doximity is due to report fiscal second-quarter results on November 5. Investors will watch how AI products such as Ask are being monetized and whether the UpToDate integration deepens engagement among physicians.



_11_19_2026_18_10_09_455845.jpg)

_11_19_2026_18_15_38_890267.jpg)
Please wait processing your request...